Back to GetFilings.com



Table of Contents



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


Form 10-Q

         
x   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2003
   
o   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                to                

Commission File Number: 000-32057
   

American Physicians Capital, Inc.

(Exact name of registrant as specified in its charter)
     
Michigan   38-3543910
(State or other jurisdiction of
incorporation or organization)
  (IRS employer
identification number)

1301 North Hagadorn Road, East Lansing, Michigan 48823

(Address of principal executive offices)(Zip Code)

Registrant’s telephone number, including area code: (517) 351-1150

Securities registered pursuant to Section 12(b) of the Act: None

Securities registered pursuant to Section 12(g) of the Act: Common Stock, no par value

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

YES  x       NO  o

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act)

YES  x       NO  o

The number of shares outstanding of the registrant’s common stock, no par value per share, as of May 13, 2003 was 8,706,533.




TABLE OF CONTENTS

TABLE OF CONTENTS
PART I. FINANCIAL INFORMATION
CONDENSED CONSOLIDATED BALANCE SHEETS
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
AMERICAN PHYSICIANS CAPITAL, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
ITEM 3. Quantitative and Qualitative Disclosures About Market Risk
PART II. OTHER INFORMATION
ITEM 6. Exhibits and Reports on Form 8-K
SIGNATURES
CERTIFICATION OF DISCLOSURE
EXHIBIT INDEX
906 Certification of Chief Executive Officer
906 Certification of Chief Financial Officer


Table of Contents

TABLE OF CONTENTS
           
PART I. FINANCIAL INFORMATION
       
 
Item 1. Financial Statements (Unaudited)
       
 
         Condensed Consolidated Balance Sheets
    3  
 
         Condensed Consolidated Statements of Income
    4  
 
         Condensed Consolidated Statements of Comprehensive Income
    5  
 
         Condensed Consolidated Statements of Cash Flows
    6  
 
         Notes to Condensed Consolidated Financial Statements
    7  
 
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
    11  
 
Item 3. Quantitative and Qualitative Disclosures About Market Risk
    20  
 
Item 4. Controls and Procedures
    21  
PART II. OTHER INFORMATION
       
 
Item 6. Exhibits and Reports on Form 8-K
    22  
Signatures
    23  
Certification of Disclosure
    24  
Exhibit Index
    26  

2


Table of Contents

PART I. FINANCIAL INFORMATION

AMERICAN PHYSICIANS CAPITAL, INC. AND SUBSIDIARIES

 
CONDENSED CONSOLIDATED BALANCE SHEETS

ITEM 1. Financial Statements

                     
March 31, December 31,
2003 2002


(Unaudited)
(In thousands, except share data)
Assets
               
Investments:
               
 
Fixed maturities, at fair value
  $ 567,731     $ 618,899  
 
Equity securities, at fair value
    2,494       44  
 
Other investments
    30,638       30,788  
   
   
 
   
Total investments
    600,863       649,731  
Cash and cash equivalents
    199,208       151,825  
Premiums receivable
    58,273       62,531  
Reinsurance recoverable
    103,113       98,128  
Federal income tax recoverable
    2,015       1,100  
Deferred federal income taxes
    41,027       42,542  
Property and equipment, net of accumulated depreciation
    14,331       14,352  
Other intangible assets
    506        
Other assets
    39,533       38,709  
   
   
 
   
Total assets
  $ 1,058,869     $ 1,058,918  
   
   
 
Liabilities
               
Unpaid losses and loss adjustment expenses
  $ 639,331     $ 637,494  
Unearned premiums
    101,013       103,420  
Note payable, officer
    6,662       6,567  
Other liabilities
    31,189       31,148  
   
   
 
   
Total liabilities
    778,195       778,629  
   
   
 
Shareholders’ Equity
               
Common stock, no par value, 50,000,000 shares authorized: 8,701,533 and 8,695,452 shares outstanding at March 31, 2003 and December 31, 2002, respectively
           
Additional paid-in-capital
    92,148       92,148  
Retained earnings
    163,198       164,183  
Unearned stock compensation
    (603 )     (678 )
Accumulated other comprehensive income:
               
 
Net unrealized appreciation on investments, net of deferred federal income taxes
    25,931       24,636  
   
   
 
   
Total shareholders’ equity
    280,674       280,289  
   
   
 
   
Total liabilities and shareholders’ equity
  $ 1,058,869     $ 1,058,918  
   
   
 

The accompanying notes are an integral part of the condensed consolidated financial statements.

3


Table of Contents

AMERICAN PHYSICIANS CAPITAL, INC. AND SUBSIDIARIES

 
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
                   
Three Months Ended
March 31,

2003 2002


(In thousands, except
per share data)
Net premiums written
  $ 54,837     $ 62,377  
Change in net unearned premiums
    3,599       (8,450 )
   
   
 
 
Net premiums earned
    58,436       53,927  
Investment income
    10,385       10,836  
Net realized losses
    (3 )     (286 )
Other income
    161       134  
   
   
 
 
Total revenues and other income
    68,979       64,611  
   
   
 
Losses and loss adjustment expenses
    55,982       57,168  
Underwriting expenses
    13,287       11,471  
Investment expenses
    551       911  
Interest expense
    95       90  
Amortization expense
    44        
General and administrative expenses
    535       400  
   
   
 
 
Total expenses
    70,494       70,040  
   
   
 
 
Loss before federal income taxes and cumulative effect of a change in accounting principle
    (1,515 )     (5,429 )
Federal income tax benefit
    (530 )     (1,900 )
   
   
 
 
Loss before cumulative effect of a change in accounting principle
    (985 )     (3,529 )
Cumulative effect of a change in accounting principle
          (9,079 )
   
   
 
 
Net loss
  $ (985 )   $ (12,608 )
   
   
 
Net loss before cumulative effect of a change in accounting principle
               
 
Basic
  $ (0.11 )   $ (0.35 )
 
Diluted
  $ (0.11 )   $ (0.35 )
Cumulative effect of a change in accounting principle
               
 
Basic
  $     $ (0.91 )
 
Diluted
  $     $ (0.91 )
Net loss per common share
               
 
Basic
  $ (0.11 )   $ (1.26 )
 
Diluted
  $ (0.11 )   $ (1.26 )

The accompanying notes are an integral part of the condensed consolidated financial statements.

4


Table of Contents

AMERICAN PHYSICIANS CAPITAL, INC. AND SUBSIDIARIES

 
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(UNAUDITED)
                       
Three Months Ended
March 31,

2003 2002


(In thousands)
Net loss
  $ (985 )   $ (12,608 )
Other comprehensive income (loss):
               
 
Unrealized appreciation (depreciation) on investment securities
    1,992       (7,416 )
   
Effect of deferred federal income taxes
    (697 )     2,595  
   
   
 
     
Comprehensive income (loss)
  $ 310     $ (17,429 )
   
   
 

The accompanying notes are an integral part of the condensed consolidated financial statements.

5


Table of Contents

AMERICAN PHYSICIANS CAPITAL, INC. AND SUBSIDIARIES

 
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
                       
Three Months Ended
March 31,

2003 2002


(In thousands)
Cash flows from operating activities
               
 
Net loss
  $ (985 )   $ (3,529 )
 
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
               
   
Depreciation and amortization
    891       776  
   
Net realized losses
    3       286  
   
Change in deferred federal income taxes
    778       3,942  
   
Increase in unpaid loss and loss adjustment expenses
    1,837       9,006  
   
Change in unearned premiums
    (2,407 )     11,153  
   
Changes in other assets and liabilities
    (2,975 )     (13,574 )
   
   
 
     
Net cash (used in) provided by operating activities
    (2,858 )     8,060  
   
   
 
Cash flows from investing activities
               
 
Purchases
               
   
Available-for-sale — fixed maturities
    (1,151 )     (67,428 )
   
Available-for-sale — equity securities
    (2,450 )      
   
Property and equipment
    (431 )     (262 )
 
Sales and maturities
               
   
Available-for-sale — fixed maturities
    54,273       10,261  
   
   
 
     
Net cash provided by (used in) investing activities
    50,241       (57,429 )
   
   
 
Cash flows from financing activities
               
 
Common stock repurchased
          (5,196 )
 
Proceeds from stock options exercised
          238  
   
   
 
     
Net cash used in financing activities
          (4,958 )
   
   
 
     
Net increase (decrease) in cash and cash equivalents
    47,383       (54,327 )
     
Cash and cash equivalents, beginning of period
    151,825       106,444  
   
   
 
     
Cash and cash equivalents, end of period
  $ 199,208     $ 52,117  
   
   
 

The accompanying notes are an integral part of the condensed consolidated financial statements.

6


Table of Contents

AMERICAN PHYSICIANS CAPITAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

1.     Basis of Presentation

      The accompanying condensed consolidated financial statements include the accounts of American Physicians Capital, Inc. (“APCapital”) and its wholly owned subsidiaries, together referred to in this report as the “Company.” All significant intercompany accounts and transactions are eliminated in consolidation.

      The Company is principally engaged in the business of providing medical professional liability and workers’ compensation insurance throughout the United States with a concentration of writings in the Midwest.

      The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and with the instructions for Form 10-Q and Rule 10-01 of Regulation S-X as they apply to interim financial information. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.

      In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. The operating results for the three-month period ended March 31, 2003 are not necessarily indicative of the results to be expected for the year ending December 31, 2003. The accompanying condensed consolidated financial statements should be read with the annual consolidated financial statements and notes contained in the Company’s Annual Report on Form 10-K for the year ended December 31, 2002.

      The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

      The most significant estimates that are susceptible to significant change in the near-term relate to the determination of the losses and loss adjustment expense reserves, investments, taxes, reinsurance and the reserve for extended reporting period claims. Although considerable variability is inherent in these estimates, management believes that the current estimates are reasonable in all material respects. The estimates are reviewed regularly and adjusted as necessary. Such adjustments are reflected in current operations.

      Certain 2002 amounts have been reclassified to conform with the 2003 presentation.

Stock-based Compensation

      The Company uses the intrinsic value-based method to account for all stock-based employee compensation plans and has adopted the disclosure-only alternative of SFAS No. 123 “Accounting for Stock-Based Compensation”, as amended by SFAS No. 148, “Accounting for Stock-Based Compensation”. In accordance with SFAS No. 123, as amended by SFAS No. 148, the Company is required to disclose the pro forma effects on operating results as if the Company had elected the fair value approach to account for all of its stock-based employee compensation plans.

7


Table of Contents

AMERICAN PHYSICIANS CAPITAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

      If compensation had been determined on the fair value at the grant date for awards in the quarters ended March 31, 2003 and 2002, respectively, consistent with the provisions of SFAS No. 123, our net loss and net loss per share would have been follows:

                   
March 31,

2003 2002


(In thousands, except
per share data)
Net loss
               
 
As reported
  $ (985 )   $ (12,608 )
 
Pro forma
  $ (1,295 )   $ (13,049 )
Stock based employee compensation expense included in reported net loss, net of related tax effects
           
Total stock based employee compensation expense determined under fair value based method for all awards granted since 2000, net of related tax
    310       441  
Diluted loss per share
               
 
As reported
  $ (0.11 )   $ (1.26 )
 
Pro forma
  $ (0.15 )   $ (1.30 )

      Such pro forma disclosures may not be representative of future compensation costs because options vest over several years and additional grants are made each year.

      The weighted-average fair value of options granted, measured on the grant date using the Black-Scholes model, was $7.93 per share for the three months ended March 31, 2002. There were no options granted during the three months ended March 31, 2003.

      The fair value of each option grant is estimated on the date of grant using the Black-Scholes valuation model with the following weighted average assumptions:

                 
2003(1) 2002


Risk-free interest rate
            4.45 %
Volatility assumption
            35.00 %
Expected life of options
            5.00  
Dividend yield
            0.00 %

(1)  There were no options granted during the three months ended March 31, 2003.

2.     Loss Per Share

      Net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock and common stock equivalents (e.g., stock options and stock awards) outstanding, calculated on a daily basis. The weighted average shares outstanding were 8,594,572 and 10,029,243 for the three months ended March 31, 2003 and 2002, respectively.

8


Table of Contents

AMERICAN PHYSICIANS CAPITAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

      The following table sets forth the computation of basic and diluted loss per common share:

                   
Three Months Ended
March 31,

2003 2002


(In thousands, except
per share data)
Numerator for basic and diluted loss per common share:
               
 
Loss before cumulative effect of a change in accounting principle
  $ (985 )   $ (3,529 )
 
Cumulative effect of a change in accounting principle
          (9,079 )
   
   
 
 
Net loss
  $ (985 )   $ (12,608 )
   
   
 
Denominator:
               
 
Denominator for basic loss per common share — weighted average shares outstanding
    8,595       10,029  
 
Effect of dilutive stock options and awards(1)
           
   
   
 
 
Denominator for diluted loss per common share — adjusted weighted average shares outstanding
  $ 8,595     $ 10,029  
   
   
 
Loss before cumulative effect of a change in accounting principle — basic
  $ (0.11 )   $ (0.35 )
Cumulative effect of a change in accounting principle — basic
  $     $ (0.91 )
Net loss — basic
  $ (0.11 )   $ (1.26 )

(1)  As the Company was in a net loss position for the three months ended March 31, 2003 and 2002, no effect of options or other stock awards was calculated as the impact would be anti-dilutive.

3.     Segment Information

      The Company is organized and operates principally in the property and casualty insurance industry and has five reportable segments — medical professional liability, workers’ compensation, health, personal and commercial, and corporate and other. The accounting policies of the segments are described in the notes to the financial statements included in the Company’s most recent Annual Report on Form 10-K.

      Expense allocations are based primarily on loss and loss adjustment expenses by line of business and certain other estimates for underwriting expenses. Investment income, investment expense, amortization expense and interest expense are allocated to the segments based on that segment’s “ownership” percentage of

9


Table of Contents

AMERICAN PHYSICIANS CAPITAL, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

the assets or liabilities underlying the income or expense. General and administrative expenses are all attributed to the holding company and are included in corporate and other.

                     
March 31, December 31,
2003 2002


(In thousands)
Total assets:
               
 
Medical professional liability
  $ 876,828     $ 859,804  
 
Workers’ compensation
    143,014       153,612  
 
Health
    14,114       19,003  
 
Personal and commercial
    3,378       4,089  
 
Corporate and other
    21,535       22,410  
   
   
 
   
Total
  $ 1,058,869     $ 1,058,918  
   
   
 
                     
Three Months Ended
March 31,

2003 2002


(In thousands)
Total revenue:
               
 
Medical professional liability
  $ 48,272     $ 41,201  
 
Workers’ compensation
    13,875       16,947  
 
Health
    6,712       5,816  
 
Personal and commercial
    (149 )     (18 )
 
Corporate and other
    269       665  
   
   
 
   
Total
  $ 68,979     $ 64,611  
   
   
 
Income (loss) before federal income taxes:
               
 
Medical professional liability
  $ (1,289 )   $ (5,925 )
 
Workers’ compensation
    252       1,657  
 
Health
    204       (1,186 )
 
Personal and commercial
    (402 )     (183 )
 
Corporate and other
    (280 )     208  
   
   
 
   
Total
  $ (1,515 )   $ (5,429 )
   
   
 

4.     Goodwill

      Effective January 1, 2002, the Company adopted Statement of Financial Accounting Standard (“SFAS”) No. 142, “Goodwill and Other Intangible Assets.” At that date, the only goodwill or other intangible asset recorded by the Company was the $13.9 million associated with the purchase of Stratton-Cheeseman Management Company in 1999. Based on the results of the impairment testing, the recorded net goodwill of $13.9 million was written off as the fair value of the Company’s reporting units did not support the carrying value of previously recorded goodwill. For purposes of the impairment testing, fair value was estimated using various methods, including multiples of projected net income and market capitalization. The goodwill impairment was recorded as a cumulative effect of a change in accounting principle, net of a deferred income tax benefit of $4.9 million. In accordance with the transition guidance given in SFAS No. 142, the goodwill impairment charge, net of tax, that was determined in the fourth quarter of 2002 was recorded in the first quarter of 2002.

10


Table of Contents

ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

      The following discussion and analysis should be read in conjunction with the condensed consolidated financial statements and the notes thereto included elsewhere in this report and the Company’s Annual Report on Form 10-K for the year ended December 31, 2002. The following discussion of our financial condition and results of operations contains certain forward-looking statements related to our anticipated future financial condition and operating results and our current business plans. When we use words such as “believes,” “expects,” “anticipates,” “estimates” or similar expressions, we are making forward-looking statements. These forward-looking statements represent our outlook only as of the date of this report. While we believe that any forward-looking statements we have made are reasonable, actual results could differ materially since these statements are based on our current expectations and are subject to risks and uncertainties. These risks and uncertainties are detailed from time to time in reports filed by the Company with the Securities and Exchange Commission. See, for example, the disclosures in “Item 1 — Business — Uncertainties Relating to Forward-Looking Statements” of the Company’s Annual Report on Form 10-K for the year ended December 31, 2002, and in other reports filed by the Company with the Securities and Exchange Commission. Other factors not currently anticipated by management may also materially and adversely affect the Company’s financial position and results of operations. The Company does not undertake, and expressly disclaims any obligation, to update or alter its forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

      The following analysis utilizes financial results and ratios that are determined in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The property/ casualty insurance industry utilizes some unique financial ratios that can be derived from GAAP amounts that help investors better understand our operations. A description of these ratios is contained in “Item 7 — Management’s Discussion and Analysis of Financial Condition and Results of Operations — Description of Ratios Analyzed” of the Company’s Annual Report on Form 10-K for the year ended December 31, 2002.

      In addition to our reported GAAP loss ratios, we also report accident year loss ratios, which exclude prior year loss reserve development. We believe this ratio is useful in evaluating our current underwriting performance, as it focuses on the relationships between current premiums earned and current losses. Our method of calculating these measures may differ from those used by other companies and, therefore, comparability may be limited.

      We operate primarily in three insurance product segments: medical professional liability, workers’ compensation, and health. Effective December 31, 2001, the Company exited the personal and commercial lines of business. The personal and commercial insurance operating segment will continue to generate income (loss) due to the development of unpaid loss and loss adjustment expenses associated with this segment. See Note 3 of the Notes to Condensed Consolidated Financial Statements, contained elsewhere in this report, for further information regarding the operating results of our business segments.

11


Table of Contents

      The following table sets forth, for the three-month periods ended March 31, 2003 and 2002, the amount of direct premiums written, net premiums written, and net premiums earned for each of our insurance operating segments.

                                     
Three Months Ended March 31,

2003 2002


% of % of
Amount Total Amount Total




(dollars in thousands)
Direct premiums written:
                               
 
Medical professional liability
  $ 47,591       77.2%     $ 45,403       64.3%  
 
Workers’ compensation
    7,226       11.7%       19,268       27.3%  
 
Health
    6,841       11.1%       5,528       7.8%  
 
Other
          0.0%       360       0.6%  
   
   
   
   
 
   
Total
  $ 61,658       100.0%     $ 70,559       100.0%  
   
   
   
   
 
Net premiums written:
                               
 
Medical professional liability
  $ 40,119       73.2%     $ 38,567       61.8%  
 
Workers’ compensation
    8,305       15.1%       18,126       29.1%  
 
Health
    6,525       11.9%       5,684       9.1%  
 
Other
    (112 )     -0.2%             0.0%  
   
   
   
   
 
   
Total
  $ 54,837       100.0%     $ 62,377       100.0%  
   
   
   
   
 
Net premiums earned:
                               
 
Medical professional liability
  $ 39,485       67.6%     $ 32,951       61.1%  
 
Workers’ compensation
    12,538       21.5%       15,292       28.4%  
 
Health
    6,525       11.2%       5,684       10.5%  
 
Other
    (112 )     -0.3%             0.0%  
   
   
   
   
 
   
Total
  $ 58,436       100.0%     $ 53,927       100.0%  
   
   
   
   
 

12


Table of Contents

Results of Operations — Three Months Ended March 31, 2003, Compared to Three Months Ended March 31, 2002

     Medical Professional Liability Insurance Operations

      The following table sets forth summary premium, loss and expense information regarding the underwriting results of our medical professional liability insurance operations for the three-month periods ended March 31, 2003 and 2002.

                                     
Percentage
2003 2002 Change Change




(dollars in thousands)
Direct premiums written:
                               
 
Michigan
  $ 8,442     $ 7,610     $ 832       10.9%  
 
Ohio
    7,905       9,020       (1,115 )     -12.4%  
 
Illinois
    12,930       7,016       5,914       84.3%  
 
Florida
    3,475       7,343       (3,868 )     -52.7%  
 
Kentucky
    8,215       10,172       (1,957 )     -19.2%  
 
New Mexico
    3,813       2,503       1,310       52.3%  
 
Nevada
    1,044       940       104       11.1%  
 
Other
    1,767       799       968       121.2%  
   
   
   
   
 
   
Total
  $ 47,591     $ 45,403     $ 2,188       4.8%  
   
   
   
   
 
Net premiums written
  $ 40,119     $ 38,567     $ 1,552       4.0%  
   
   
   
   
 
Net premiums earned
  $ 39,485     $ 32,951     $ 6,534       19.8%  
Incurred loss and loss adjustment expenses:
                               
 
Current year losses
    40,186       38,474       1,712       4.4%  
 
Prior year losses
    1,000       1,500       (500 )     -33.3%  
   
   
   
   
 
   
Total
    41,186       39,974       1,212       3.0%  
Underwriting expenses
    7,816       6,395       1,421       22.2%  
   
   
   
   
 
Underwriting loss
  $ (9,517 )   $ (13,418 )   $ 3,901       -29.1%  
   
   
   
   
 
Loss ratio:
                               
 
Calendar year
    104.3%       121.3%       -17.0%          
 
Accident year
    101.8%       116.8%       -15.0%          
Underwriting expense ratio
    19.8%       19.4%       0.4%          
Combined ratio:
                               
 
Calendar year
    124.1%       140.7%       -16.6%          
 
Accident year
    121.6%       136.2%       -14.6%          

      The increase in direct premiums written was primarily the result of premium rate increases. Although the Company has experienced significant policy growth in its Illinois market, it has been mostly offset by a decrease in the number of policies in-force in its Kentucky and Ohio markets, primarily due to significant rate increases and tighter underwriting standards in those markets. In addition, there has been a significant decrease in the number of policies in-force in our Florida market, as described below. The Company is continually seeking regulatory approval of additional rate increases.

      In the second quarter of 2002, the Company announced its intention to discontinue writing medical professional liability insurance in Florida. Medical professional liability direct premiums written in the state of Florida for the year ended December 31, 2002 were $23.6 million, and the Company reported net loss and loss adjustment expenses for that period of $35.2 million relating to its Florida business. The Florida Department of Insurance has approved the Company’s plan to exit this market and in October 2002, the Company began mailing non-renewal notices to medical professional liability policyholders whose renewals would have been effective in December 2002. Florida law requires the Company to offer extended reporting coverage for previously insured periods, commonly referred to as “tail policies,” at the time of non-renewal. Tail policies

13


Table of Contents

typically have written premiums of approximately two times the last annual policy premium. The Company expects that some physicians will opt for this extended reporting coverage, which will result in additional direct premiums written in 2003. The amount of these future premiums cannot be reasonably estimated due to the uncertainty regarding the number of physicians who will opt for the coverage.

      In January 2003, the Company invested in a start up insurance company managed by the Company’s former third-party-administrator who underwrote its Florida medical professional liability business. This start up insurance company, Physicians Insurance Company, would seek to write as many of the tail policies as its capital and surplus levels would permit, thereby limiting APCapital’s direct exposure to future losses associated with underwriting Florida medical professional liability extended reporting period coverages.

      Net premiums earned increased 19.8%, compared to a 4.8% increase in direct premiums written. The increase in net premiums earned was greater than the increase in direct premiums written as premiums written in 2002 continue to be earned in the first quarter of 2003.

      The decrease in the loss ratio for the three months ended March 31, 2003, compared to the same period in 2002, was primarily the result of the premium rate increases described above.

      Prior accident year loss reserves have developed unfavorably in the first quarter of 2003 by approximately $1 million. This unfavorable development primarily relates to accident years 1999 through 2001 in the Company’s Ohio occurrence market. Claims on occurrence business tend to take longer to be reported than on claims-made medical professional liability policies. In 1999, Ohio was a relatively new market for the Company. The newness of the market, together with the extended reporting period on the Ohio occurrence business, made it difficult for the Company to estimate incurred but not reported claims. In 2002, the Company ceased writing occurrence business in Ohio. Without the unfavorable development on prior accident years, the loss ratio for the three months ended March 31, 2003 would have been 101.8%, which compares favorably with the accident year loss ratio of 106.1% for the entire 2002 accident year. The 4.3% decrease in the accident year loss ratio from accident year 2002 to 2003 was primarily the result of premium rate increases, the exit of our Florida market, as described above, and enhanced claims management.

      The increase in the underwriting expense ratio was primarily the result of a decrease in our ceded commission rate to 20% for the 2003 treaty year, from 25% for the 2002 treaty year. In addition, the Company paid $225,000, its deductible amount, to settle a bad faith claim in Florida during the three months ended March 31, 2003.

      The principal agency through which the Company writes medical professional liability insurance is SCW Agency Group, Inc. (“SCW”), which is principally owned by William Cheeseman, the Company’s president and chief executive officer. The Company’s relationship with SCW is more fully described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2002. During the three months ended March 31, 2003, direct premiums written for the Company by SCW totaled $17.7 million and commissions incurred related to SCW totaled $1.4 million, compared to $19.6 million and $1.6 million, respectively, during the three months ended March 31, 2002.

14


Table of Contents

     Workers’ Compensation Insurance Operations

      The following table sets forth summary premium, loss and expense information regarding the underwriting results of our workers’ compensation insurance operations for the three-month periods ended March 31, 2003 and 2002.

                                     
Percentage
2003 2002 Change Change




(dollars in thousands)
Direct premiums written:
                               
 
Minnesota
  $ 3,743     $ 10,119     $ (6,376 )     -63.0%  
 
Michigan
    1,676       3,007       (1,331 )     -44.3%  
 
Illinois
    1,047       1,485       (438 )     -29.5%  
 
Indiana
    565       1,410       (845 )     -59.9%  
 
Kentucky
    88       2,458       (2,370 )     -96.4%  
 
Iowa
    90       363       (273 )     -75.2%  
 
Other
    17       426       (409 )     -96.0%  
   
   
   
   
 
   
Total
  $ 7,226     $ 19,268     $ (12,042 )     -62.5%  
   
   
   
   
 
Net premiums written
  $ 8,305     $ 18,126     $ (9,821 )     -54.2%  
   
   
   
   
 
Net premiums earned
  $ 12,538     $ 15,292     $ (2,754 )     -18.0%  
Incurred loss and loss adjustment expenses:
                               
 
Current year losses
    10,045       12,240       (2,195 )     -17.9%  
 
Prior year losses
    (800 )     (1,000 )     200       -20.0%  
   
   
   
   
 
   
Total
    9,245       11,240       (1,995 )     -17.7%  
Underwriting expenses
    4,283       3,886       397       10.2%  
   
   
   
   
 
Underwriting (loss) gain
  $ (990 )   $ 166     $ (1,156 )     -696.4%  
   
   
   
   
 
Loss ratio:
                               
 
Calendar year
    73.7%       73.5%       0.2%          
 
Accident year
    80.1%       80.0%       0.1%          
Underwriting expense ratio
    34.2%       25.4%       8.8%          
Combined ratio:
                               
 
Calendar year
    107.9%       98.9%       9.0%          
 
Accident year
    114.3%       105.4%       8.9%          

      The decrease in direct premiums written was primarily the result of the Company’s efforts to restructure its workers’ compensation book of business as described below.

      In June 2002, the Company filled several executive and management positions in its workers’ compensation segment to improve the overall performance of this segment, reduce risk exposure and improve profitability. In the fourth quarter of 2002, the Company began to exit the Kentucky workers’ compensation market, as well as non-renew certain higher-risk construction industry policies in all markets. These actions had the effect of significantly decreasing workers’ compensation direct premiums written for the three months ended March 31, 2003 compared to the same period of 2002. We expect direct premiums written to continue to decrease in the near future as we complete these restructuring efforts, but we expect growth in direct written premiums written later in 2003 after the planned changes have been implemented. These efforts to restructure the book of business include exiting certain higher-risk specialties (e.g., construction industry policies) and poor performing markets, and replacing this business with smaller accounts in industries with lower risk and mid-level accounts in underserved markets where we can add value with accident prevention and assertive claims management services.

      The decrease in net premiums earned was not as great as the decrease in direct premiums written as premiums written in 2002 continue to be earned in 2003.

15


Table of Contents

      On a calendar year and accident year basis, the workers’ compensation loss ratio was relatively consistent with the prior year, as losses decreased at a rate similar to the decrease in net premiums earned. As a result of our exit from certain underperforming markets, as described above, and improved claim processing, we experienced an $800,000 favorable adjustment to prior year loss and loss adjustment expense reserves.

      The increase in the underwriting expense ratio resulted primarily from the Company’s hiring of several workers’ compensation executives and managers in mid-2002, as well as severance costs related to the restructuring of this segment.

     Health Insurance Operations

      The following table sets forth summary premium, loss and expense information regarding the underwriting results of our health insurance operations for the three-month periods ended March 31, 2003 and 2002.

                                     
Percentage
2003 2002 Change Change




(dollars in thousands)
Direct premiums written
  $ 6,841     $ 5,528     $ 1,313       23.8%  
   
   
   
   
 
Net premiums written
  $ 6,525     $ 5,684     $ 841       14.8%  
   
   
   
   
 
Net premiums earned
  $ 6,525     $ 5,684     $ 841       14.8%  
Incurred loss and loss adjustment expenses:
                               
 
Current year losses
    5,861       5,796       65       1.1%  
 
Prior year losses
    (468 )                 0.0%  
   
   
   
   
 
   
Total
    5,393       5,796       (403 )     -7.0%  
Underwriting expenses
    1,104       1,194       (90 )     -7.5%  
   
   
   
   
 
Underwriting gain (loss)
  $ 28     $ (1,306 )   $ 1,334       -102.1%  
   
   
   
   
 
Loss ratio:
                               
 
Calendar year
    82.7%       102.0%       -19.3%          
 
Accident year
    89.8%       102.0%       -12.2%          
Underwriting expense ratio
    16.9%       21.0%       -4.1%          
Combined ratio:
                               
 
Calendar year
    99.6%       123.0%       -23.4%          
 
Accident year
    106.7%       123.0%       -16.3%          

      All health direct premiums written were related to our involvement with a single preferred provider organization located in western Michigan. This coverage is provided as part of our long-term strategic relationship with the physician organization that sponsors this plan. The increase in direct premiums written was the result of premium rate increases, offset by a decrease in the number of covered lives. The following table shows the number of covered lives and the per-member-per-month (“PMPM”) premium at March 31, 2003, December 31, 2002, and March 31, 2002.

                   
Covered PMPM
Lives Premium


Month Ended:
               
 
March 31, 2003
    10,438     $ 208.02  
 
December 31, 2002
    12,898     $ 188.28  
 
March 31, 2002
    11,410     $ 160.20  
Change:
               
 
March 2003 vs. December 2002
    (2,460 )   $ 19.74  
 
March 2003 vs. March 2002
    (972 )   $ 47.82  

      The increase in net premiums earned was less than the increase in direct premiums written due to a change in reinsurance which resulted in additional ceded premiums.

16


Table of Contents

      The decrease in the loss and loss adjustment expense ratio was primarily the result of premium rate increases combined with tighter underwriting standards. The favorable development on prior year loss and loss adjustment expense reserves was the result of re-underwriting efforts in 2002.

      The decrease in the underwriting ratio was primarily due to the reduction of certain corporate overhead expenses related to the health insurance segment.

          Personal and Commercial Lines Insurance Operations

      The Company’s personal and commercial insurance product segment experienced an underwriting loss of $354,000 for the three months ended March 31, 2003, compared to an underwriting loss of $154,000 for the three months ended March 31, 2002. This segment will continue to generate income (loss) due to the development of unpaid loss and loss adjustment expenses.

          Corporate and Other

      Investment income, excluding net realized investment losses, was $10.4 million for the three months ended March 31, 2003, a decrease of $451,000, or 4.2%, compared to the three months ended March 31, 2002. The decrease in investment income was the result of the Company’s unusually large cash position during the first quarter of 2003, and low short-term interest rates, compared to the same period of 2002. The Company delayed investing a portion of its cash flow during the first quarter of 2003 due to the very low interest rate environment and its reluctance to lock-in long term interest rates at prevailing levels. The average yield on the Company’s cash and cash equivalents was approximately 1% during the three months ended March 31, 2003, which reduced the Company’s average yield on its investment portfolio down to 5.48% for the three months ended March 31, 2003, compared to 5.84% for the same period of 2002. Net realized losses were $3,000 and $286,000 during the three-month periods ended March 31, 2003 and 2002, respectively.

      The market value of the Company’s fixed income security portfolio is inversely related to interest rates. Therefore, as interest rates have declined, the market value of the Company’s fixed income security portfolio has increased. Unrealized gains, net of deferred federal income taxes, on the Company’s investments were $25.9 million at March 31, 2003, an increase of $1.3 million compared to December 31, 2002.

      Investment expenses were $551,000 during the three months ended March 31, 2003. This represents a decrease of $360,000, or 39.5%, compared to the same period of 2002. The decrease in investment expenses was primarily due to higher depreciation expense on several of the Company’s investment real estate properties in the first quarter of 2002.

      The Company’s general and administrative expenses increased $135,000 to $535,000 during the three months ended March 31, 2003, compared to the same period of 2002. The increase was primarily the result of a new errors and omissions liability insurance policy acquired in mid 2002.

      The Company recorded amortization expense of $44,000 during the three months ended March 31, 2003, on a definite-lived intangible asset acquired in connection with its investment in Physicians Insurance Company. The Company did not record any amortization expense in the first quarter of 2002. The investment in Physicians Insurance Company is discussed under “—Results of Operations — Three Months Ended March 31, 2003 Compared to Three Months Ended March 31, 2002 — Medical Professional Liability Insurance Operations”.

      The Company recorded $530,000 in federal income tax benefit for the three months ended March 31, 2003, compared to a $1.9 million benefit during the same period of 2002. The effective tax rate was 35.0% for the three months ended March 31, 2003, and 2002.

      Net loss for the three months ended March 31, 2003 was $985,000 on revenues of $69.0 million, compared to a net loss of $3.5 million on revenues of $64.6 million for the three months ended March 31, 2002. The decrease in the net loss was due primarily to premium rate increases and enhanced claims management in our Medical Professional Liability operating segment.

17


Table of Contents

          Liquidity, Capital Resources and Financial Condition

      The primary sources of our liquidity, on both a short- and long-term basis, are funds provided by insurance premiums collected, net investment income, recoveries from reinsurance, and proceeds from the maturity or sale of invested assets. The primary uses of cash, on both a short- and long-term basis, are losses, loss adjustment expenses, operating expenses, reinsurance premiums, and taxes.

      APCapital is a holding company whose only material assets are the capital stock of APAssurance and its other subsidiaries, and cash. APCapital’s ongoing cash flow will consist primarily of dividends and other permissible payments from its subsidiaries and investment earnings on funds held. The payment of dividends to APCapital by its insurance subsidiaries is subject to limitations imposed by applicable state law.

      The Company’s only indebtedness is to its President and Chief Executive Officer (“CEO”) in the amount of $8.0 million (reflected on our balance sheet at its present value of $6.7 million) in connection with the purchase of Stratton Cheeseman Management Company. The indebtedness is due in annual installments with the final installment due April 2008. See table at the end of this section for further information regarding the timing and amounts of these payments. The amount of the annual payments will increase or decrease by $200,000 for each corresponding half-grade level increase or decrease in the Company’s A.M. Best Company, Inc. rating. Certain events, such as the termination, death or disability of the President and CEO, or a change in control of the Company, could accelerate these payments.

      At December 31, 2002, the Company had planned expenditures of approximately $3.4 million related to various information technology initiatives. At March 31, 2003, these expenditures are progressing as planned.

      The Company’s net cash flow used in operations was approximately $2.9 million for the three months ended March 31, 2003, compared to $8.1 million provided by operations for the three months ended March 31, 2002. The decrease was primarily the result of the decrease in direct premiums written to $61.7 million for the three months ended March 31, 2003, from $70.6 million for the three months ended March 31, 2002.

      At March 31, 2003, the Company had $199.2 million of cash available and an investment portfolio of $600.9 million. The portfolio includes $22.9 million of bonds maturing in the next year. On a long-term basis, fixed income securities are purchased on a basis intended to provide adequate cash flows from future maturities. As of March 31, 2003, $358.9 million of bonds mature in the next one to five years and $167.5 million mature in the next six to ten years. In addition, the Company has $1.8 million of mortgage-backed securities that provide periodic principal repayments.

      Premiums receivable decreased $4.2 million to $58.3 million at March 31, 2003, compared to $62.5 million at December 31, 2002. The decrease is directly attributable to the $8.9 million decrease in direct premiums written during the three months ended March 31, 2003 compared to the same period of 2002.

      Reinsurance recoverable increased $5.0 million to $103.1 million at March 31, 2003, compared to $98.1 million at December 31, 2002. The increase was primarily the result of higher medical professional liability case reserves, as the claims staff for that segment continues to enhance its claims handling process. We have a net reinsurance recoverable from Gerling Global (“Gerling”) of approximately $10 million. In 2002, Gerling’s parent company put Gerling’s United States subsidiary into run off resulting in a series of A.M. Best rating downgrades for Gerling. We continue to believe that Gerling has adequate surplus and cash flow to satisfy its obligations to us and we have not experienced any difficulties in collecting amounts due from Gerling. However, we are continuing to monitor Gerling and may pursue an economic settlement or commutation with Gerling, which could require us to recognize a loss, if we determine that is the best long-term course of action.

      Loss and loss adjustment expense reserves increased $1.8 million, or 0.3% to $639.3 million at March 31, 2003, from $637.5 million at December 31, 2002. This increase was due to increased writings in the medical professional liability lines.

      The unearned premium reserve decreased $2.4 million, or 2.3%, to $101.0 million at March 31, 2003, from $103.4 million at December 31, 2002. The decrease was primarily due to decreased policy counts in our

18


Table of Contents

Kentucky and Ohio medical professional liability markets, which renew in January, as well as the decrease in workers’ compensation direct premiums written.

      In March, July and November 2001, May 2002, and twice in August 2002, APCapital’s Board of Directors authorized six separate programs to purchase 5% of its outstanding common stock, representing a total of approximately 3,115,000 shares. APCapital’s purchase of any of its shares is subject to limitations that may be imposed by applicable securities laws and regulations and the rules of the Nasdaq Stock Market. The timing of the purchases and the number of shares to be bought at any one time depend on market conditions and the Company’s capital requirements. During the first quarter of 2003, APCapital did not repurchase any shares under these authorizations. A total of 2,924,270 shares have been repurchased pursuant to these authorizations through March 31, 2003, at a cost of $52.7 million. As of March 31, 2003, the Company has approximately 191,000 shares of its August 28, 2002 stock repurchase program remaining to be purchased under the existing authorizations. There can be no assurance that the Company will repurchase the remaining shares authorized to be purchased, or that any additional repurchases will be authorized by the Company’s Board of Directors.

      The Company expects to borrow between $15 million and $30 million during the second quarter of 2003 to increase its available cash resources and surplus. This indebtedness is expected to have a term of approximately 30 years. Based on historical trends, market conditions and our business plans, we believe that our existing resources and sources of funds, including these borrowings, will be sufficient to meet our short-term and long-term liquidity needs. However, economic, market and regulatory conditions may change, and there can be no assurance that our funds will be sufficient to meet our short-term liquidity needs.

      The following table shows (in thousands) the nature and timing of the Company’s contractual obligations as of March 31, 2003.

                                           
Payments Due by Period

Less Than 1 - 3 3 - 5 More Than
Contractual Obligations Total 1 Year Years Years 5 Years






Note payable to officer
  $ 8,000     $ 1,000     $ 2,000     $ 3,000     $ 2,000  
Operating leases
    3,205       1,297       1,367       541        
   
   
   
   
   
 
 
Total
  $ 11,205     $ 2,297     $ 3,367     $ 3,541     $ 2,000  
   
   
   
   
   
 

Significant Accounting Policies

      The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect amounts reported in the accompanying condensed consolidated financial statements and related footnotes. These estimates and assumptions are evaluated on an on-going basis based on historical developments, market conditions, industry trends and other information we believe to be reasonable under the circumstances. There can be no assurance that actual results will conform to our estimates and assumptions, and that reported results of operations will not be materially adversely affected by the need to make accounting adjustments to reflect changes in these estimates and assumptions from time to time.

      The policies relating to unpaid losses and loss adjustment expenses, investments, taxes, reinsurance and the reserve for extended reporting period claims are those we believe to be the most sensitive to estimates and judgments. They are more fully described in Item 7 of our most recent Annual Report on Form 10-K and in Note 1 to our consolidated financial statements contained in that report. There have been no material changes to these policies during the most recent quarter or the estimates made pursuant to those policies.

Effects of New Accounting Pronouncements

      The Financial Accounting Standards Board (“FASB”) has recently issued several new Statements and Interpretations. In addition, the American Institute of Certified Public Accountants (“AICPA”) has issued a number of new Statements of Position (“SOP”). None of the newly promulgated FASB Statements or

19


Table of Contents

Interpretations, or the AICPA SOPs are expected to have a material impact on the Company’s financial position or results of operations for the year ended December 31, 2003.

ITEM 3.     Quantitative and Qualitative Disclosures About Market Risk

General

      Market risk is the risk of loss due to adverse changes in market rates and prices. As of March 31, 2003, the majority of our investment portfolio was invested in fixed maturity securities, which are interest-sensitive assets, and cash and cash equivalents. Accordingly, our primary market risk is exposure to changes in interest rates. The fixed maturity securities primarily consisted of U.S. government and agency bonds, high-quality corporate bonds, mortgage-backed securities and tax-exempt U.S. municipal bonds.

Qualitative Information About Market Risk

      Investments in our portfolio have varying degrees of risk. The primary market risk exposure to the fixed maturity portfolio is interest rate risk, which is limited somewhat by our management of duration. The distribution of maturities and sector concentrations are monitored on a regular basis.

      We periodically review the investment portfolio for any potential credit quality or collection issues and for any securities with respect to which we consider any decline in market value to be other than temporary. Investments which are considered to be other than temporarily impaired (“OTTI”) are written down to their estimated net realizable value. We utilize both quantitative and qualitative evaluation methods to evaluate the potential for OTTI. At March 31, 2003, approximately 94.2% of our fixed maturity portfolio (excluding approximately $4 million of private placement issues) was considered investment grade. There were no impairments during the quarter ended March 31, 2003.

      In addition to the OTTI write downs noted above, we are closely monitoring $6.5 million of enhanced equipment trust certificates we own that were issued by Delta Airlines. These certificates had an unrealized loss of approximately $2.5 million at March 31, 2003. These certificates have experienced a significant decline in market value only during the last six months. We believe this unrealized loss is a temporary condition at March 31, 2003. However, if the outlook for Delta does not improve in the second quarter, we believe a write down of the Delta certificates as of June 30, 2003 may be necessary.

Quantitative Information About Market Risk

      At March 31, 2003, our fixed income security portfolio was valued at $567.7 million and had an average modified duration of 3.31 years, compared to a portfolio valued at $618.9 million with an average modified duration of 3.20 years at December 31, 2002. The following table shows the effects of a change in interest rates on the fair value and duration of our portfolio. We have assumed an immediate increase or decrease of 1% or 2% in interest rate for illustrative purposes. You should not consider this assumption, or the values shown in the table, to be a prediction of actual future results.

                                                 
March 31, 2003 December 31, 2002


Portfolio Change in Modified Portfolio Change in Modified
Change in Rates Value Value Duration Value Value Duration







(dollars in thousands) (dollars in thousands)
+2%
  $ 531,819     $ (35,912 )     3.05     $ 581,066     $ (37,833 )     2.94  
+1%
    548,833       (18,898 )     3.15       599,244       (19,655 )     2.97  
0
    567,731               3.31       618,899               3.20  
-1%
    587,471       19,740       3.36       639,729       20,830       3.26  
-2%
    608,323       40,592       3.46       661,713       42,814       3.37  

20


Table of Contents

ITEM 4.     Controls and Procedures

      Within the 90 days prior to the date of this report, the Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including its Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Rule 13a-15 of the Securities Exchange Act of 1934. Based upon that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective to cause material information required to be disclosed by the Company in the reports it files or submits under the Securities Exchange Act of 1934, to be recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. There have been no significant changes in the Company’s internal controls or in other factors which could significantly affect internal controls subsequent to the date the Company carried out its evaluation.

21


Table of Contents

PART II. OTHER INFORMATION

ITEM 6.     Exhibits and Reports on Form 8-K

      (a) Exhibits.

  99.1  Certification by the Chief Executive Officer pursuant to 18 U.S.C. Section 1350.
 
  99.2  Certification by the Chief Financial Officer pursuant to 18 U.S.C. Section 1350.

      (b) Reports on Form 8-K.

      There were no Reports on Form 8-K filed during the three months ended March 31, 2003.

22


Table of Contents

SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: May 15, 2003

  AMERICAN PHYSICIANS CAPITAL, INC.

  By:  /s/ WILLIAM B. CHEESEMAN
 
  William B. Cheeseman
  Its: President and Chief Executive Officer

  By:  /s/ FRANK H. FREUND
 
  Frank H. Freund
  Its: Executive Vice President, Treasurer,
  Chief Financial Officer and
  principal accounting officer

23


Table of Contents

  CERTIFICATION OF DISCLOSURE

        I, William B. Cheeseman certify that:

        1. I have reviewed this quarterly report on Form 10-Q of American Physicians Capital, Inc.;
 
        2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;
 
        3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;
 
        4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

        a. designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
 
        b. evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the “Evaluation Date”); and
 
        c. presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

        5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

        a. all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and
 
        b. any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and

        6. The registrant’s other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

Date: May 15, 2003

  /s/ WILLIAM B. CHEESEMAN
 
  William B. Cheeseman
  President and Chief Executive Officer
  American Physicians Capital, Inc.

24


Table of Contents

CERTIFICATION OF DISCLOSURE

      I, Frank H. Freund certify that:

        1. I have reviewed this quarterly report on Form 10-Q of American Physicians Capital, Inc.;
 
        2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;
 
        3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;
 
        4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

        a. designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
 
        b. evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the “Evaluation Date”); and
 
        c. presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

        5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

        a. all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and
 
        b. any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and

        6. The registrant’s other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

Date: May 15, 2003

  /s/ FRANK H. FREUND
 
  Frank H. Freund
  Executive Vice President, Treasurer,
  Chief Financial Officer and
  principal accounting officer
  American Physicians Capital, Inc.

25


Table of Contents

EXHIBIT INDEX
         
Exhibit No. Exhibit Description


  99.1     Certification by the Chief Executive Officer pursuant to 18 U.S.C. Section 1350.
  99.2     Certification by the Chief Financial Officer pursuant to 18 U.S.C. Section 1350.

26